Searched for
BSV
Mankind Pharma completes Rs 13,768 cr BSV acquisitionMankind Pharma has completed the acquisition of Bharat Serums and Vaccines Ltd for Rs 13,768 crore. This acquisition strengthens Mankind Ph...- Mankind can clear debt taken for BSV buy in 3 years: MD Rajeev JunejaMankind Pharma aims to clear its ₹13,630-crore debt from acquiring Bharat Serums and Vaccines within three years, according to MD Rajeev Ju...
- Market not much enthused by Mankind's BSV buyAfter initially cheering the deal, the stock market gave its thumbs-down to Mankind acquiring BSV at the premium valuations of eight times ...
- Mankind Pharma taps Barclays and Deutsche Bank for Rs 13,630 cr acquisition of Bharat Serums & VaccinesMankind Pharma has appointed Barclays and Deutsche Bank to arrange financing for its Rs 13,630 crore acquisition of Bharat Serums & Vaccine...
- Mankind to use debt, internal accruals to fund BSV buyoutMankind Pharma announced a ₹13,630 crore acquisition of Bharat Serums and Vaccines (BSV) to be funded through internal accruals and a mix o...
- Mankind Pharma shares fall 2.5% after BSV acquisitionMankind Pharma Share Price: Mankind Pharma shares dropped by 2.5% following the announcement of a Rs 13,630 crore acquisition of Bharat Ser...
- Mankind trumps EQT-ADIA to buy BSV for $1.67 bnThis is the largest acquisition by Mankind Pharma, India’s 4th largest pharma company by market share. A formal announcement regarding the ...
- Mankind Pharma competes with EQT-ADIA combo for Rs 14,000 cr buyout of BSV Group from AdventThe buyout of BSV Group (formerly Bharat Serum & Vaccines Ltd) is contested by Mankind Pharma and EQT with ADIA, each offering around Rs 14...
- Mankind Pharma in race with PEs to buy BSV Group at possible valuation of Rs 13,000 croreWarburg Pincus, ChrysCapital, TPG, Blackstone, EQT, Mankind Pharma, and Dr Reddy's Laboratories are competing to acquire BSV Group, a bioph...
- Crypto exchange Binance seeks to slash size of $13 billion UK lawsuitLawyers representing BSV Claims, a vehicle set up to pursue the case, say the exchanges engaged in anti-competitive behaviour to delist BSV...
- Crypto exchange Binance seeks to slash size of $13 billion UK lawsuitBinance and Kraken are being sued in London over claims of colluding to delist Bitcoin Satoshi Vision (BSV), causing its value to drop and ...
- Global private equity firms eye $1 billion bid for Bharat Serums and vaccinesFive global private equity firms, including Warburg Pincus, Permira, EQT, Bain, and TPG, are interested in bidding for Bharat Serums and Va...
- BSV acquires Malaysia based drug, devices distribution cosThe financial details of the acquisition were not disclosed. Following the acquisition, the two companies will be held by BSV.
- Bharat Serums and Vaccines acquires key women health brand Tidilan from Jagdale IndustriesTidilan is used for relaxing uterine muscles to prevent premature labour, among expecting mothers. It belongs to a class of medication call...
- Advent backed-BSV to buy TTK Healthcare's pharma business for Rs 805 crThe portfolio of TTK which is heavy on infertility and gynecology is complementary to BSV's portfolio. TTK's top brands include Ossopan (ca...
- Government extends NCLT Acting President BSV Prakash Kumar's tenure for one monthThis is the second extension of BSV Prakash Kumar, who was appointed as Acting President of NCLT for a period of three months from January ...
- Advent set to buy controlling stake in Bharat SerumKotak PE and OrbiMed together that hold 23% stake in Mumbai-based biopharma company Bharat Serums and Vaccines (BSV) are exiting through th...
- Advent International emerges sole bidder for Bharat SerumsKotak PE and OrbiMed together hold 23% stake in BSV. The rest of the stake is with the Daftary family.
- Carlyle-Zydus and Advent join race to acquire Bharat Serums and Vaccines LtdThey are up against domestic pharma companies Dr Reddy's Labs, Mankind & Goldman Sachs which have also made offers.
- Cadila buys JV partner's 50 pc stake in Zydus BSV PharmaZydus BSV Pharma, founded in 2005, is a joint venture (JV) company of Cadila Healthcare and biotech firm Bharat Serums and Vaccines (BSV).
Load More
